Development Level

Tbio 2 | 10,625
Tchem 2 | 1,890

Disease

Cancer 4 | 2,346
Asthma 3 | 349
Lung Neoplasms 3 | 171
Amphetamine-Related Disorders 2 | 74
Chromosome Aberrations 2 | 15
Colorectal Neoplasms 2 | 217
Diabetes Mellitus, Non-Insulin-Dependent 2 | 157
Drug-Induced Liver Injury 2 | 118
Endometriosis 2 | 535
Liver Cirrhosis, Experimental 2 | 108
Liver disease 2 | 219
Liver diseases 2 | 66
Male infertility 2 | 170
Micronuclei, Chromosome-Defective 2 | 19
Non-alcoholic Fatty Liver Disease 2 | 40
Prostatic Neoplasms 2 | 471
Raynaud disease 2 | 6
Renal Cell Carcinoma 2 | 199
Squamous cell carcinoma 2 | 94
glioblastoma 2 | 5,572
osteosarcoma 2 | 7,933
psoriasis 2 | 6,685
Adenoma 1 | 165
Adverse reaction to drug 1 | 54
Asbestosis 1 | 10
Asthenozoospermia 1 | 3
Atherosclerosis 1 | 275
Atopic dermatitis 1 | 944
Atrophic 1 | 10
Autistic Disorder 1 | 320
Autoimmune hepatitis 1 | 13
Autoimmune polyendocrine syndrome 1 | 6
Bladder Neoplasm 1 | 109
Cardiovascular system disease 1 | 194
Chloracne 1 | 32
Chronic Obstructive Airway Disease 1 | 47
Chronic obstructive pulmonary disease 1 | 146
Dermatologic disorders 1 | 65
Drug allergy 1 | 36
Growth Disorders 1 | 33
Hepatomegaly 1 | 10
Hypertensive disease 1 | 193
Kidney Neoplasm 1 | 27
Leukemia 1 | 88
Liver Neoplasms, Experimental 1 | 48
Liver carcinoma 1 | 217
Liver neoplasms 1 | 109
Lung Injury 1 | 20
Malaria 1 | 140
Mesothelioma 1 | 40
Methemoglobinemia 1 | 17
Multiple myeloma 1 | 1,327
Neoplasms, Second Primary 1 | 6
Neural Tube Defects 1 | 27
Neurodegenerative Disorders 1 | 37
Pain agnosia 1 | 99
Parkinson Disease 1 | 102
Peripheral Neuropathy 1 | 303
Porphyria cutanea tarda 1 | 12
Precursor Cell Lymphoblastic Leukemia Lymphoma 1 | 42
Schistosomiasis 1 | 38
Schizophrenia 1 | 501
Splenic Diseases 1 | 3
Splenomegaly 1 | 7
Squamous cell carcinoma of esophagus 1 | 82
Testicular Germ Cell Tumor 1 | 22
Toxic encephalopathy 1 | 131
Urticaria 1 | 53
Vascular disease 1 | 281
active Crohn's disease 1 | 918
colon cancer 1 | 1,475
ductal carcinoma in situ 1 | 1,745
group 3 medulloblastoma 1 | 2,254
intraductal papillary-mucinous adenoma (IPMA) 1 | 2,956
intraductal papillary-mucinous carcinoma (IPMC) 1 | 2,988
intraductal papillary-mucinous neoplasm (IPMN) 1 | 3,289
invasive ductal carcinoma 1 | 2,950
lung adenocarcinoma 1 | 2,713
lung cancer 1 | 4,466
lung carcinoma 1 | 2,844
medulloblastoma, large-cell 1 | 6,234
non-small cell lung cancer 1 | 2,798
oligodendroglioma 1 | 2,849
ovarian cancer 1 | 8,484
pediatric high grade glioma 1 | 2,712
pilocytic astrocytoma 1 | 3,086
subependymal giant cell astrocytoma 1 | 2,287
substance-related disorder 1 | 105
uncontrolled asthma 1 | 67

Tissue

Blood and immune system 4 | 17,995
Cardiovascular System 4 | 17,958
Digestive Tract 4 | 18,473
Endocrine System 4 | 18,512
Female tissues 4 | 18,647
Liver and Pancreas 4 | 18,136
Male tissues 4 | 17,969
Nervous System 4 | 18,561
Respiratory system 4 | 17,484
Urinary Tract 4 | 18,444
Skin and soft tissues 3 | 18,115

Target Family

Enzyme 3 | 4,146
Non-IDG 1 | 11,971

Grant Application

5R01CA070913-08 4 | 4
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Glutathione S-transferase theta-1 GSTT1 Tbio Enzyme -2.91242 860.0 0
Glutathione S-transferase Mu 1 GSTM1 Tbio Enzyme -3.26145 1954.9 331
Cytochrome P450 1A2 CYP1A2 Tchem Non-IDG -3.30248 2022.5 420
Hematopoietic prostaglandin D synthase HPGDS Tchem Enzyme -3.70187 4165.3 68